Zimmer Biomet PPS RingLoc+ Acetabular Shell Recall: Missing Etching Hazard
Zimmer Biomet recalls PPS RingLoc+ Acetabular Shell models with missing etching that could affect surgical fit. Affected units include model 11-116062, lot 374670. Consumers should contact the company for details.
Recall notice
Device was distributed with the etching missing from the product.
Contact the company
What happened, in plain English
Zimmer Biomet is recalling PPS RingLoc+ Acetabular Shells with missing etching that could lead to improper surgical fit. This recall affects patients who received the specific model during surgery. Read more at govinfonow.com/recall/73509-zimmer-biomet-pps-ringloc-acetabular-shell-recall-missing-etching-hazard.
Source Summary by GovInfoNow · govinfonow.com/recall/73509-zimmer-biomet-pps-ringloc-acetabular-shell-recall-missing-etching-hazard · Updated September 21, 2026 · FDA enforcement record: FDA #Z-0312-2018
Cite this page
“Zimmer Biomet PPS RingLoc+ Acetabular Shell Recall: Missing Etching Hazard.” GovInfoNow, updated September 21, 2026. https://govinfonow.com/recall/73509-zimmer-biomet-pps-ringloc-acetabular-shell-recall-missing-etching-hazard. Based on FDA recall #Z-0312-2018 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0312-2018%22&limit=1).
Why it’s dangerous
The etching missing from the product could cause improper surgical fit during hip replacement procedures. This might lead to complications like improper alignment or instability of the implant.
Who’s affected
Patients who received the PPS RingLoc+ Acetabular Shell model 11-116062 with lot number 374670 during surgery are affected. Surgeons and medical teams using this specific implant are most at risk.
How to tell if you have this one
Check for model number 11-116062 and lot number 374670 on the implant packaging or surgical documentation. The recall applies to the PPS RingLoc+ Acetabular Shell used in hip replacement surgeries.
- Brand
Zimmer Biomet- Category
Medical device
What to do — step by step
Contact Zimmer Biomet
Reach out to Zimmer Biomet directly for specific instructions on how to handle the recalled implant.
Where it went and when
Where it was distributed
Distributed in 3 states.
FDA distribution: “Distributed domestically to MI, MN, ND.” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Michigan, Minnesota, North Dakota.
Recall timeline
FDA terminated this recall 8 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest medical device recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #Z-0312-2018 (June 29, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0312-2018 to see it in context.
- Plain-language summary written by qwen3:4b on September 21, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.